An estimated 1 in 500 people in the U.S. are living with hypertrophic cardiomyopathy (HCM) -; the most common inherited heart disease -; and many are unaware.

The Zacks Medical - Products industry’s revenues are expected to continue to grow due to robust demand for surgeries and ...

Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...

Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...

This year has seen sharp stock moves as companies report financial results and update investors on early and mid-stage drug studies ...

Global CAR-T Cell Therapy Market Zooms 6.2X to Touch Whopping USD 57 Billion by 2030. Global CAR-T Cell Therapy Market is thriving due to increasing prevalence of cancer, a spurri ...

Bristol Myers Squibb Co. closed $2.39 below its 52-week high ($61.08), which the company reached on November 11th.